avapro has been researched along with Sleep Apnea Syndromes in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
| Excerpt | Relevance | Reference |
|---|---|---|
| "ARB prevents chronic sleep apnea-enhanced cardiac apoptosis via enhancing survival pathways." | 1.72 | Angiotensin II receptor blocker irbesartan attenuates sleep apnea-induced cardiac apoptosis and enhances cardiac survival and Sirtuin 1 upregulation. ( Huang, CY; Lee, SD; Lin, CY; Lin, YY; Liou, YF; Pai, PY; Wong, JKS; Wu, XB; Yu, SH, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pai, PY | 1 |
| Lin, YY | 1 |
| Yu, SH | 1 |
| Lin, CY | 1 |
| Liou, YF | 1 |
| Wu, XB | 1 |
| Wong, JKS | 1 |
| Huang, CY | 1 |
| Lee, SD | 1 |
1 other study available for avapro and Sleep Apnea Syndromes
| Article | Year |
|---|---|
Angiotensin II receptor blocker irbesartan attenuates sleep apnea-induced cardiac apoptosis and enhances cardiac survival and Sirtuin 1 upregulation.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Hypo | 2022 |